Genetic determinants of immunogenicity to factorIXduring the treatment of haemophilia B-Reference-Cited by-同舟云学术

Genetic determinants of immunogenicity to factorIXduring the treatment of haemophilia B

Author:

Saini S.¹²,Hamasaki‐Katagiri N.¹,Pandey G. S.¹,Yanover C.³,Guelcher C.²,Simhadri V. L.¹,Dandekar S.⁴,Guerrera M. F.²⁵,Kimchi‐Sarfaty C.¹,Sauna Z. E.¹

Affiliation:

1. Laboratory of Hemostasis Division of Hematology Center for Biologics Evaluation and Research Food and Drug Administration Silver Spring MD USA

2. Center for Cancer and Blood Disorders Children's National Health System Washington DC USA

3. Machine Learning for Healthcare and Life Sciences IBM Research Laboratory Haifa Israel

4. Department of Human Genetics David Geffen School of Medicine Los Angeles CA USA

5. School of Medicine and Health Sciences George Washington University Washington DC USA

Funder

U.S. Food and Drug Administration

Publisher

Wiley

Subject

Genetics (clinical),Hematology,General Medicine

Link

Reference43 articles.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献